Based on SEC filing data. A biotech corporation based in Ann Arbor, Michigan, in its growth stage, raised $60.0 million in equity funding. The company operates in the biotechnology sector.
Get notified the moment ONL Therapeutics, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.